Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders

References

Agarwal, P. and Searls, D.B. (2008). Literature mining in support of drug discovery. Briefings Bioinf. 9, 479–492.10.1093/bib/bbn035Search in Google Scholar

Alawieh, A., Zaraket, F.A., Li, J., Mondello, S., Nokkari, A., Razafsha, M., Fadlallah, B., Boustany, R., and Kobeissy, F.H. (2012). Systems biology, bioinformatics, and biomarkers in neuropsychiatry. Front Psychiatry 6, 1–16.10.3389/fnins.2012.00187Search in Google Scholar

Alvarez, Y.D., Fauerbach, J.A., Pellegrotti, J.V., Jovin, T.M., Jares-Erijman, E.A., and Stefani, F.D. (2013). Influence of gold nanoparticles on the kinetics of α-synuclein aggregation. Nano Lett. 13, 6156–6163.10.1016/j.bpj.2013.11.1513Search in Google Scholar

Alzheimer’s Association. (2016). Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 12.10.1016/j.jalz.2016.03.001Search in Google Scholar

Andreasen, N., Minthon, L., and Davidsson, P. (2001). Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch. Neurol. 58, 373–379.10.1001/archneur.58.3.373Search in Google Scholar

Andreasen, N., Sjogren, M., and Blennow, K. (2003). CSF markers for Alzheimer’s disease: total tau, phospho-tau and A42. World J. Biol. Psychiatry 4, 147–155.10.1080/15622970310029912Search in Google Scholar

Baker, N.C. and Hemminger, B.M. (2010). Mining connections between chemicals, proteins, and diseases extracted from Medline annotations. J. Biomed. Inform. 43, 510–519.10.1016/j.jbi.2010.03.008Search in Google Scholar

Balenahalli, N.R., Rao, T.S.S., Annamalai, P., Kumar, S., and Rao, K.S.J. (2010). Neuronutrition and Alzheimer’s disease. J. Alzheimers Dis. 19, 1123–1139.10.3233/JAD-2010-1312Search in Google Scholar

Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer’s disease. Lancet 377, 1019–1031.10.1016/S0140-6736(10)61349-9Search in Google Scholar

Bard, J.B. and Rhee, S.Y. (2004). Ontologies in biology: design, applications and future challenges. Nat. Rev. Genet. 5, 213–222.10.1038/nrg1295Search in Google Scholar PubMed

Berezovska, O., Ramdya, P., and Skoch, J. (2003). Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-γ-secretase complex in cells demonstrated by fluorescence lifetime imaging. J. Neurosci. 23, 4560–4566.10.1523/JNEUROSCI.23-11-04560.2003Search in Google Scholar

Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., and Greenamyre, J.T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat. Neurosci. 3, 1301–1306.10.1038/81834Search in Google Scholar

Bhat, K., Wang, F., Ma, Q., Li, Q., Mallik, S., Hsieh, T., and Wu, E. (2012). Advances in biomarker research for pancreatic cancer. Curr. Pharm. Des. 18, 2439–2451.10.2174/13816128112092439Search in Google Scholar

Binetti, G., Signorini, S., and Squitti. R. (2003). Atypical dementia associated with a novel presenilin-2 mutation. Ann. Neurol. 54, 832–836.10.1002/ana.10760Search in Google Scholar

Blennow, K. and Vanmechelen, E. (2003). CSF markers for pathogenic processes in Alzheimer’s disease: diagnostic implications and use in clinical neurochemistry. Brain Res. Bull. 61, 235–242.10.1016/S0361-9230(03)00086-8Search in Google Scholar

Bodenreider, O. and Stevens, R. (2006). Bio-ontologies: current trends and future directions. Briefings Bioinf. 7, 256–274.10.1093/bib/bbl027Search in Google Scholar PubMed PubMed Central

Bonifati, V., Rizzu, P., and Baren, M.J. (2003). Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. Science 299, 256–259.10.1126/science.1077209Search in Google Scholar PubMed

Burgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., and Beach, T. (2014). Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology. PLoS One 9, e94839.10.1371/journal.pone.0094839Search in Google Scholar PubMed PubMed Central

Burns, A. and Iliffe, S. (2009). Alzheimer’s disease. Br. Med. J. 338, b158.10.1136/bmj.b158Search in Google Scholar PubMed

Cannon, J.R., Tapias, V., Na, H.M., Honick, A.S., Drolet, R.E., and Greenamyre, J.T. (2009). A highly reproducible rotenone model of Parkinson’s disease. Neurobiol. Dis. 34, 279–290.10.1016/j.nbd.2009.01.016Search in Google Scholar PubMed PubMed Central

Chen, H., Huang, X., Guo, X., Mailman, R.B., Park, Y., and Kamel, F. (2010). Smoking duration, intensity, and risk of Parkinson disease. Neurology 74, 878–884.10.1212/WNL.0b013e3181d55f38Search in Google Scholar PubMed PubMed Central

Chen, L., Yoo, S.E., Na, R., Liu, Y., and Ran, Q. (2012). Cognitive impairment and increased Aβ levels induced by paraquat exposure are attenuated by enhanced removal of mitochondrial H₂O₂. Neurobiol. Aging 33, e15–432.e26.10.1016/j.neurobiolaging.2011.01.008Search in Google Scholar PubMed

Cheng, L., Quek, C.Y.J., Sun, X., Bellingham, S.A., and Hill, A.F. (2013). The detection of microRNA associated with Alzheimer’s disease in biological fluids using next-generation sequencing technologies. Front Genet. 4, 150.10.3389/fgene.2013.00150Search in Google Scholar PubMed PubMed Central

Choi, J., Lee, H.W., and Suk, K. (2011). Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease. J. Neurol. 258, 2181–2185.10.1007/s00415-011-6087-9Search in Google Scholar PubMed

Christian, H. (2011). Identifying and validating biomarkers for Alzheimer’s disease. Trends Biotechnol. 29, 26–32.10.1016/j.tibtech.2010.09.007Search in Google Scholar PubMed PubMed Central

Chun, H.W., Tsuruoka, Y., and Kim, J.D. (2006). Extraction of gene-disease relations from Medline using domain dictionaries and machine learning. Pac. Symp. Biocomput. 11, 4–15.10.1142/9789812701626_0002Search in Google Scholar

Cogswell, J.P., Ward, J., Taylor, I.A., Waters, M., Shi, Y., and Cannon, B. (2008). Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 14, 27–41.10.3233/JAD-2008-14103Search in Google Scholar

Daily News Analysis (DNA). (2015). World Alzheimer’s Day 2015: 4.1 million people in India living with dementia, says report. September 21, 2015, 06:42 PM IST. www.dnaindia.com.Search in Google Scholar

Das, S.K., Misra, A.K, Ray, B.K., Hazra, A., Ghosal, M.K., Chaudhuri, A., Roy, T., Banerjee, T.K., and Raut, D.K. (2010). Epidemiology of Parkinson disease in the city of Kolkata, India: a community-based study. Neurology 75, 1362–1369.10.1212/WNL.0b013e3181f735a7Search in Google Scholar PubMed PubMed Central

Decressac, M., Volakakis, N., Björklund, A., and Perlmann, T. (2013). NURR1 in Parkinson disease – from pathogenesis to therapeutic potential. Nat. Rev. Neurol. 9, 629–636.10.1038/nrneurol.2013.209Search in Google Scholar PubMed

DeMaagd, G. and Philip, A. (2015). Parkinson’s disease and its management; part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. Pharm. Ther. 40, 504–510, 532.Search in Google Scholar

Desrosiers, R.R., Bertrand, Y., and Nguyen, Q.T. (2003). Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer’s disease. Biochem. J. 374, 463–471.10.1042/bj20030240Search in Google Scholar

Diao, H., Li, X., Hu, S., and Liu, Y. (2012). Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease. PLoS One 7, e52319.10.1371/journal.pone.0052319Search in Google Scholar PubMed PubMed Central

Driver, J.A., Beiser, A., Au, R., Kreger, B.E., Splansky, G.L., Kurth, T., Kiel, D.P., Lu, K.P., Seshadri, S., and Wolf, P.A. (2012). Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study. Br. Med. J. 344, e1442.10.1136/bmj.e1442Search in Google Scholar PubMed PubMed Central

El-Agnaf, O.M.A. and Irvine, G.B. (2001). Aggregation and neurotoxicity of-synuclein and related peptides. Biochem. Soc. Trans. 30, 559–565.10.1042/bst0300559Search in Google Scholar PubMed

El-Assaad, A., Dawy, Z., Nemer, G., and Kobeissyb, F. (2017). Novel bioinformatics-based approach for proteomic biomarkers prediction of calpain-2 and caspase-3 protease fragmentation: application to βII-spectrin protein. Sci. Rep. 7, 41039.10.1038/srep41039Search in Google Scholar PubMed PubMed Central

Fang, F.C. and Casadevall, A. (2011). Reductionist and holistic science. Infect. Immun. 79, 1401–1404.10.1128/IAI.01343-10Search in Google Scholar PubMed PubMed Central

Farrer, M.J. (2006). Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 7, 306–318.10.1038/nrg1831Search in Google Scholar PubMed

Farrer, L.A., Cupples, L.A., and Haines, J.L. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta-Analysis Consortium. J. Am. Med. Assoc. 278, 1349–1356.10.1001/jama.278.16.1349Search in Google Scholar

Food and Drug Administration, H.H.S. (2011). International Conference on Harmonisation; guidance on E16 biomarkers related to drug or biotechnology product development: context, structure, and format of qualification submissions; availability. Fed. Reg. 76, 49773–49774.Search in Google Scholar

Frijters, R., Van, V.M., and Smeets, R. (2010). Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput. Biol. 6, 1–11.e1000943.10.1371/journal.pcbi.1000943Search in Google Scholar PubMed PubMed Central

Fujimura, M., Usuki, F., Sawada, M., and Takashima, A. (2009). Methyl mercury induces neuro pathological changes with tau hyper phosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30, 1000–1007.10.1016/j.neuro.2009.08.001Search in Google Scholar PubMed

Giglio, P. and Gilbert, M.R. (2010). Neurologic complications of cancer and its treatment. Curr. Oncol. Rep. 12, 50–59.10.1007/s11912-009-0071-xSearch in Google Scholar PubMed PubMed Central

Giovannucci, E., Harlan, D.M., Archer, M.C., Bergenstal, R.M., Gapstur, S.M., Habel, L.A., Pollak, M., Regensteiner, J.G., and Yee, D. (2010). Diabetes and cancer: a consensus report. Diabetes Care. 33, 1674–1685.10.2337/dc10-0666Search in Google Scholar

Goldman, S.M., Kamel, F., Ross, G.W., Jewell, S.A., Bhudhikanok, G.S., Umbach, D., Marras, C., Hauser, R.A., Stewart, J.J., Bressman, S., et al. (2012). Head injury, alpha-synuclein Rep1 and Parkinson’s disease. Ann. Neurol. 71, 40–48.10.1002/ana.22499Search in Google Scholar

Gong, G. and O’Bryant, S.E. (2010). The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 24, 311–316.10.1097/WAD.0b013e3181d71bc7Search in Google Scholar

Gorman, C. (2010). A healthy brain needs a healthy heart. Sci. American https://www.scientificamerican.com.Search in Google Scholar

Gourmaud, S., Paquet, C., Dumurgier, J., Pace C., Bouras, C., Gray, F., Laplanche, J.L., Meurs, E.F., Mouton-Liger, F., and Hugon, J. (2015). Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline. J. Psychiatry Neurosci. 40, 151–161.10.1503/jpn.140062Search in Google Scholar

Greco, I., Day, N., Riddoch, C.J., Reed, J., Soininen, H., Oszewska, I.K., Tsolaki, M., Vellas, B., Spenger, C., Mecocci, P., et al. (2012). Alzheimer’s disease biomarker discovery using in silico literature mining and clinical validation. J. Transl. Med. 10, 217.10.1186/1479-5876-10-217Search in Google Scholar

Harischandra, D.S., Jin, H., Anantharam, V., Kanthasamy, A., and Kanthasamy, A.G. (2015). α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease. J. Toxicol. Sci. 143, 454–468.10.1093/toxsci/kfu247Search in Google Scholar

Harrington, M.G., Fonteh, A.N., and Biringer, R.G. (2006). Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology. Dis. Markers 22, 73–81.10.1155/2006/241817Search in Google Scholar

Hatcher, J.M., Pennell, K.D., and Miller, G.W. (2008). Parkinson’s disease and pesticides: a toxicological perspective. Trends Pharmacol. Sci. 29, 322–329.10.1016/j.tips.2008.03.007Search in Google Scholar

Hesse, C., Rosengren, L., and Andreasen, N. (2001). Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett. 297, 187–190.10.1016/S0304-3940(00)01697-9Search in Google Scholar

Hood, L. and Perlmutter, R.M. (2004). The impact of systems approaches on biological problems in drug discovery. Nat. Biotechnol. 22, 1215–1217.10.1038/nbt1004-1215Search in Google Scholar PubMed

Hu, Z., Huang, H., Wu, C.H., Jung, M., Dritschilo, A., Riegel, A.T., and Wellstein, A. (2011). Omics-based molecular target and biomarker identification. Methods Mol. Biol. 719, 547–571.10.1007/978-1-61779-027-0_26Search in Google Scholar PubMed PubMed Central

Huang, W.S., Chiang, Y.H., and Lin, J.C. (2003). Crossover study of ^99mTc-TRODAT-1 SPECT and ¹⁸F-FDOPA PET in Parkinson’s disease patients. J. Nucl. Med. 44, 999–1005.Search in Google Scholar

Huang, C.L., Hsiao, I.L., Lin, H.C., Wang C.F., Huang Y.J., and Chuang C.Y. (2015). Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells. Environ. Res. 136, 253–263.10.1016/j.envres.2014.11.006Search in Google Scholar PubMed

Hubble, J.P., Cao, T., Hassanein, R.E., Neuberger, J.S., and Koller, W.C. (1993). Risk factors for Parkinson’s disease. Neurology 43, 1693–1697.10.1212/WNL.43.9.1693Search in Google Scholar PubMed

Ideker, T., Galitski, T., and Hood, L. (2001). A new approach to decoding life: systems biology. Annu. Rev. Genomics Hum. Genet. 2, 343–372.10.1146/annurev.genom.2.1.343Search in Google Scholar PubMed

Jain, K.K. (2010). The Handbook of Biomarker (Springer). New York, NY: Humana Press. doi.org/10.1007/978-1-4939-7431-3.10.1007/978-1-60761-685-6Search in Google Scholar

Janssen, J.C., Beck, J.A., Campbell, T.A., Dickinson, A., Fox, N.C., Harvey, R.J., Houlden, H., Rossor, M.N. and Collinge, J. (2003). Early onset familial Alzheimer’s disease: mutation frequency in 31 families. Neurology 60, 235–239.10.1212/01.WNL.0000042088.22694.E3Search in Google Scholar

Jeffrey, S.S. and Mark, M.G. (2009). Fluorine-18 radiolabeled PET tracers for imaging monoamine transporters: dopamine, serotonin, and norepinephrine. PET Clin. 4, 101–128.10.1016/j.cpet.2009.05.006Search in Google Scholar PubMed PubMed Central

Jensen, L.J., Saric, J., and Bork, P. (2006). Literature mining for the biologist: from information retrieval to biological discovery. Nat. Rev. Genet. 7, 119–129.10.1038/nrg1768Search in Google Scholar PubMed

Jenssen, T.K., Laegreid, A., and Komorowski, J. (2001). A literature network of human genes for high-throughput analysis of gene expression. Nat. Genet. 28, 21–28.10.1038/ng0501-21Search in Google Scholar PubMed

Jiang, L.F., Yao, T.M., Zhu, Z.L., Wang, C., and Ji, L.N. (2007). Impacts of Cd (II) on the conformation and self-aggregation of Alzheimer’s tau fragment corresponding to the third repeat of microtubule-binding domain. Biochim. Biophys. Acta 1774, 1414–1421.10.1016/j.bbapap.2007.08.014Search in Google Scholar PubMed

Kala, S.V. and Jadhav, A.L. (1995). Low level lead exposure decreases in vivo release of dopamine in the rat nucleus accumbens: a microdialysis study. J. Neurochem. 65, 1631–1635.10.1046/j.1471-4159.1995.65041631.xSearch in Google Scholar

Karen, E.M. (2003). Parkin mutations and early onset Parkinsonism. Brain 126, 1250–1251.10.1093/brain/awg189Search in Google Scholar

Karsenti, E. (2012). Towards an “oceans systems biology”. Mol. Syst. Biol. 8, 1–2.10.1038/msb.2012.8Search in Google Scholar

Kaur, M., MacPherson, C.R., Schmeier, S., Narasimhan, K., Choolani, M., and Bajic, V.B. (2011). In silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer. BMC Syst. Biol. 5, 144.10.1186/1752-0509-5-144Search in Google Scholar

Killick, R., Ribe, E.M., Al-Shawi, R., Malik, B., Hooper, C., Fernandes, C., Dobson, R., Nolan, P.M., Lourdusamy, A., Furney, S., et al. (2014). Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol. Psychiatry 19, 88–98.10.1038/mp.2012.163Search in Google Scholar

Kim, D.K., Seo, M.Y., and Lim, S., (2001). Serum melanotransferrin, p97 as a biochemical marker of Alzheimer’s disease. Neuropsychopharmacology 25, 84–90.10.1016/S0893-133X(00)00230-XSearch in Google Scholar

Kim, Y.S, Maruvada, P., and Milner, J.A. (2008). Metabolomics in biomarker discovery: future uses for cancer prevention. Future Oncol. 4, 93–102.10.2217/14796694.4.1.93Search in Google Scholar PubMed

Kim, R.Y., Xu, H., Myllykangas, S., and Ji, H. (2011). Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer. Pers. Med. 8, 331–345.10.2217/pme.11.16Search in Google Scholar PubMed PubMed Central

Kim, D., Paik, J.H., Shin, D.W., Kim, H.S., Park, C.S., and Kang, J.H. (2014). What is the clinical significance of cerebrospinal fluid biomarkers in Parkinson’s disease? Is the significance diagnostic or prognostic? Exp. Neurobiol. 23, 352–364.10.5607/en.2014.23.4.352Search in Google Scholar PubMed PubMed Central

Kitano, H. (2002). Systems biology: a brief overview. Science 295, 1662–1664.10.1126/science.1069492Search in Google Scholar PubMed

Kumar, A., Mann, S., Sossi, V., Ruth, T.J., Stoessl, A.J., Schulzer, M., and Lee, C.S. (2003). [¹¹C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson’s disease. Brain 126, 2648–2655.10.1093/brain/awg270Search in Google Scholar

Lambert, J.C., Coyle, N., and Lendon, C. (2004). The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease. J. Med. Genet. 41, 104–112.10.1136/jmg.2003.005033Search in Google Scholar

Langston, J.W., Forno, L.S., Rebert, C.S., and Irwin, I. (1984). Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6 tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292, 390–394.10.1016/0006-8993(84)90777-7Search in Google Scholar

Le, W.D., Rowe, D., and Jankovic, J. (1999). Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Arch. Neurol. 56, 194–200.10.1001/archneur.56.2.194Search in Google Scholar PubMed

Leroy, E., Boyer, R., and Auburger, G. (1998). The ubiquitin pathway in Parkinson’s disease. Nature 395, 451–452.10.1038/26652Search in Google Scholar PubMed

Li, W.J., Jiang, H., Song, N., and Xie, J.X. (2010). Dose- and time-dependent alpha-synuclein aggregation induced by ferricironin SK-N-SH cells. Neurosci. Bull. 26, 205–210.10.1007/s12264-010-1117-7Search in Google Scholar PubMed PubMed Central

Li, X., Lv, Y., Yu, S., Zhao, H., and Yao, L. (2012). The effect of cadmium on a beta levels in APP/PS1transgenicmice. Exp. Ther. Med. 4, 125–130.10.3892/etm.2012.562Search in Google Scholar PubMed PubMed Central

Li, X., Ma, Y., Wei, X., Li, Y., Wu, H., Zhuang, J., and Zhao, Z. (2014). Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-β. Neurosci. Bull. 30, 162–168.10.1007/s12264-013-1391-2Search in Google Scholar PubMed PubMed Central

Li, G., Kim, C., Kim, J., Yoon, H., Zhou, H., and Kim, J. (2015). Common pesticide, dichlorodiphenyltrichloroethane (DDT), increases amyloid-β levels by impairing the function of ABCA1 and IDE: implication for Alzheimer’s disease. J. Alzheimer’s Dis. 46, 109–122.10.3233/JAD-150024Search in Google Scholar PubMed

Lim, N.K., Villemagne, V.L., Soon, C.P., Laughton, K.M., Rowe, C.C., McLean, C.A., Masters, C.L., Evin, G., and Li, Q.X. (2011). Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer’s disease. J Alzheimer’s Dis. 26, 779–786.10.3233/JAD-2011-101974Search in Google Scholar PubMed

Lim, J.K.H., Li, Q-X, He, Z., Vingrys, A.J., Wong, V.H.Y., Currier, N., Mullen, J., Bui, B.V., and Nguyen, C.T.O. (2016). The eye as a biomarker for Alzheimer’s disease. Front. Neurosci. 10, 536–549.10.3389/fnins.2016.00536Search in Google Scholar PubMed PubMed Central

Liu, M., Choi, D.Y., Hunter, R.L., Pandya, J.D., Cass, W.A., and Sullivan, P.G. (2010). Trichloroethylene induces dopaminergic neurodegeneration in Fisher rats. J. Neurochem. 112, 773–783.10.1111/j.1471-4159.2009.06497.xSearch in Google Scholar PubMed PubMed Central

Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R., and Freedman, N.D. (2012). Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am. J. Epidemiol. 175, 1200–1207.10.1093/aje/kwr451Search in Google Scholar PubMed PubMed Central

Lowe, J., McDermott, H., and Landon, M. (1990). Ubiquitin carboxylterminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161, 153–160.10.1002/path.1711610210Search in Google Scholar PubMed

Lucas, M., Laplaze, L., and Bennett, M.J. (2011). Plant systems biology: network matters. Plant Cell Environ. 34, 535–553.10.1111/j.1365-3040.2010.02273.xSearch in Google Scholar PubMed

Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L., and Di Monte, D.A. (2002). The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and α-synuclein. J. Biol. Chem. 277, 1641–1644.10.1074/jbc.C100560200Search in Google Scholar PubMed

Manschot, S.M., Biessels, G.J., Rutten, G.E., Kessels, R.P., Gispen, W.H., and Kappelle, L.J. (2008). Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J. Neurol. Sci. 264, 157–162.10.1016/j.jns.2007.08.011Search in Google Scholar PubMed

Mayeux, R. and Stern, Y. (2012). Epidemiology of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006239.10.1101/cshperspect.a006239Search in Google Scholar PubMed PubMed Central

Mayeux, R., Saunders, A.M., and Shea, S. (1998). Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. Alzheimer’s Disease Centers Consortium on Apolipoprotein E and Alzheimer’s Disease. N. Engl. J. Med. 338, 506–511.10.1056/NEJM199802193380804Search in Google Scholar PubMed

McCormack, A.L., Atienza, J.G., Johnston, L.C., Andersen, J.K., Vu, S., and Di Monte, D.A. (2005). Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93, 1030–1037.10.1111/j.1471-4159.2005.03088.xSearch in Google Scholar PubMed

Mehta, S., Shelling, A., Muthukaruppan, A., Lasham, A., Blenkiron, C., Laking, G., and Print, C. (2010). Predictive and prognostic molecular markers for cancer medicine. Ther. Adv. Med. Oncol. 2, 125–148.10.1177/1758834009360519Search in Google Scholar

Michell, A.W., Lewis, S.J.G., Foltynie, T., and Barker, R.A. (2004). Biomarkers and Parkinson’s disease. Brain 127, 1693–1705.10.1093/brain/awh198Search in Google Scholar

Miller, D.B. and O’Callaghan, J.P. (2015). Biomarkers of Parkinson’s disease: present and future. Metabolism 64, S40–S46.10.1016/j.metabol.2014.10.030Search in Google Scholar

Mohamed, A.N., Ebrahim, S.A., Sarkar, F.H., Uberti, J., and Wolman, S.R. (1995). Detection of M-bcr/abl fusion by fluorescence in situ hybridization (FISH) in a case of Ph negative CML. Cancer Genet. Cytogenet. 80, 60–62.10.1016/0165-4608(94)00118-USearch in Google Scholar

Monnet-Tschudi, F., Zurich, M.G., Boschat, C., Corbaz, A., and Honegger, P. (2006). Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev. Environ. Health 21, 105–117.10.1515/REVEH.2006.21.2.105Search in Google Scholar

Naylor, S. (2003). Biomarkers: current perspectives and future prospects. Expert Rev. Mol. Diagn. 3, 525–529.10.1586/14737159.3.5.525Search in Google Scholar

Opeskin, K. and Anderson, R.M. (1997). Suspected MPTP-induced Parkinsonism. J. Clin. Neurosci. 4, 366–370.10.1016/S0967-5868(97)90110-7Search in Google Scholar

Ori, A., Wilkinson, M.C., and Fernig, D.G. (2011). A systems biology approach for the investigation of the heparin/heparan sulfate interactome. J. Biol. Chem. 286, 19892–19904.10.1074/jbc.M111.228114Search in Google Scholar

Pandey, J., Dwivedi, A., Saxena, V.L., and Tripathi, B.K. (2013). Identification and in silico observation of potential biomarkers in breast cancer region using bioinformatics approaches. Int. J. Comput. Bioinfo. In Silico Model. 2, 147–151.Search in Google Scholar

Perl, D.P. and Olanow, C.W. (2007). The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 66, 675–682.10.1097/nen.0b013e31812503cfSearch in Google Scholar

Pezzoli, G., Ricciardi, S., Masotto, C., Mariani, C.B., and Carenzi, A. (1990). n-Hexane induces parkinsonism in rodents. Brain Res. 531, 355–357.10.1016/0006-8993(90)90801-HSearch in Google Scholar

Picillo, M., Moccia, M., Spina, E., Barone, P., and Pellecchia, M.T. (2016) Biomarkers of Parkinson’s disease: recent insights, current challenges, and future prospects. J. Parkinsonism Restless Legs Syndr. 6, 1–3.Search in Google Scholar

Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R.J., McDonald, N., et al. (2007). The mitochondrial protease HtrA2 is regulated by Parkinson’s disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243–1252.10.1038/ncb1644Search in Google Scholar PubMed

Potts, S.J., Krueger, J.S., Landis, N.D., Eberhard, D.A., Young, G.D., Schmechel, S.C., and Lange, H. (2012). Models and techniques: evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue. Lab. Investig. 92, 1342–1357.10.1038/labinvest.2012.91Search in Google Scholar PubMed

Prassas, I., Chrystoja, C.C., Makawita, S., and Eleftherios, P. (2012). Bioinformatics identification of proteins with tissue-specific expression for biomarker discovery. BMC Med. 10, 1–13.10.1186/1741-7015-10-39Search in Google Scholar PubMed PubMed Central

Purkerson-Parker, S., McDaniel, K.L., and Moser, V.C. (2001). Dopamine transporter binding in the rat striatum is increased by gestational, perinatal and adolescent exposure to heptachlor. Toxicol. Sci. 64, 216–223.10.1093/toxsci/64.2.216Search in Google Scholar PubMed

Qu, X.A., Gudivada, R.C., and Jegga, A.G. (2009). Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships. BMC Bioinformat. 10, S4.10.1186/1471-2105-10-S5-S4Search in Google Scholar PubMed PubMed Central

Ramirez, A., Heimbach, A., and Grundemann, J. (2006). Hereditary Parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184–1191.10.1038/ng1884Search in Google Scholar PubMed

Ransohoff, D.F. (2003). Cancer. Developing molecular biomarkers for cancer. Science 299, 1679–1680.10.1126/science.1083158Search in Google Scholar PubMed

Raza, K. (2010). Application of data mining in bioinformatics. Ind. J. Comput. Sci. Eng. 1, 114–118.Search in Google Scholar

Reitz, C. and Mayeux, R. (2014). Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640–651.10.1016/j.bcp.2013.12.024Search in Google Scholar PubMed PubMed Central

Richardson, J.R., Roy, A., Shalat, S.L., von Stein, R.T., Hossain, M.M., and Duan, B. (2014). Elevated serum pesticide levels and risk for Alzheimer disease. J. Am. Med. Assoc. Neurol. 71, 284–290.10.1001/jamaneurol.2013.6030Search in Google Scholar PubMed PubMed Central

Riesterer, O., Milas, L., and Ang, K.K. (2007). Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. J. Clin. Oncol. 25, 4075–4083.10.1200/JCO.2007.11.8497Search in Google Scholar PubMed

Robeva, R. (2010). Systems biology – old concepts, new science, new challenges. Front Psychiatry 1, 1–2.10.3389/fpsyt.2010.00001Search in Google Scholar

Rosner, S., Giladi, N., and Orr-Urtreger, A. (2008). Advances in the genetics of Parkinson’s disease. Acta Pharmacol. Sin. 29, 21–34.10.1111/j.1745-7254.2008.00731.xSearch in Google Scholar

Rutgers Biomedical and Health Sciences. (2014). DDT pesticide exposure linked to Alzheimer’s disease, study shows. Science Daily. 27 January.Search in Google Scholar

Sato, Y., Suzuki, I., Nakamura, T., Bernier, F., Aoshima, K., and Oda, Y. (2012). Identification of a new plasma biomarker of Alzheimer’s disease using metabolomics technology. J. Lipid Res. 53, 567–576.10.1194/jlr.M022376Search in Google Scholar

Schatzkin, A., Subar, A.F., Thompson, F.E., Harlan, L.C., Tangrea, J., and Hollenbeck, A.R. (2001). Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am. J. Epidemiol. 154, 1119–1125.10.1093/aje/154.12.1119Search in Google Scholar

Shen, L., Lin, Y., Sun, Z., Yuan, X., Chen, L., and Shen, B. (2016). Knowledge-guided bioinformatics model for identifying autism spectrum disorder diagnostic microRNA biomarkers. Sci. Rep. 6, 39663.10.1038/srep39663Search in Google Scholar

Sherer, T.B., Kim, J.H., Betarbet, R., and Greenamyre, J.T. (2003). Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp. Neurol. 179, 9–16.10.1006/exnr.2002.8072Search in Google Scholar

Sherif, F.F., Zayed, N., and Fakhr, M. (2015). Discovering Alzheimer genetic biomarkers using Bayesian networks. Adv. Bioinformat. 2015, 639367.10.1155/2015/639367Search in Google Scholar

Shin, R.W., Kruck, T.P., Murayama, H., and Kitamoto, T. (2003). A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyper phosphorylated tau of Alzheimer’s disease. Brain Res. 961, 139–146.10.1016/S0006-8993(02)03893-3Search in Google Scholar

Sian-Hülsmann, J., Mandel, S, Youdim, M.B., and Riederer, P. (2011). The relevance of iron in the pathogenesis of Parkinson’s disease. J. Neurochem. 118, 939–957.10.1111/j.1471-4159.2010.07132.xSearch in Google Scholar PubMed

Singhrao, S.K., Harding, A., Poole, S., Kesavalu, L., and Crean, S.J. (2015). Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer’s disease. Mediators Inflamm. 2015, 137357.10.1155/2015/137357Search in Google Scholar PubMed PubMed Central

Sjogren, M., Andreasen, N., and Blennow, K. (2003). Advances in the detection of Alzheimer’s disease-use of cerebrospinal fluid biomarkers. Clin. Chim. Acta 332, 1–10.10.1016/S0009-8981(03)00121-9Search in Google Scholar

Sneed, A. (2014). DDT, other environmental toxins linked to late onset Alzheimer’s disease. Scientific American, a division of Nature America, Inc. https://www.scientificamerican.com/article/studies-link-ddt-other-environmental-toxins-to-late-onset-alzheimers-disease/.Search in Google Scholar

Song, J.W. and Choi, B.S. (2013). Mercury induced the accumulation of amyloid β (Aβ) in PC12 cells: the role of production and degradation of abeta. Toxicol. Res. 29, 235–240.10.5487/TR.2013.29.4.235Search in Google Scholar PubMed PubMed Central

Steven, T.D. and Gandy, S. (2014). Environmental exposures and the risk for Alzheimer disease: can we identify the smoking guns? J. Am. Med. Assoc. Neurol. 71, 273–275.10.1001/jamaneurol.2013.6031Search in Google Scholar PubMed PubMed Central

Stoicea, N., Du, A., Lakis, D.C., Tipton, C., Arias-Morales, C.E., and Bergese, S.D. (2016). The miRNA journey from theory to practice as a CNS Biomarker. Front Genet. 7, 1–8.10.3389/fgene.2016.00011Search in Google Scholar PubMed PubMed Central

Suh, K.S., Sarojini, S., Youssif, M., Nalley, K., Milinovikj, N., Elloumi, F., Russell, S., Pecora, A., Schecter, E. and Goy, A. (2013). Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine. J. Oncol. 368751, 1–12.10.1155/2013/368751Search in Google Scholar PubMed PubMed Central

Sun, F., Anantharam, V., Latchoumycandane, C., Kanthasamy, A., and Kanthasamy, A.G. (2005). Dieldrin induces ubiquitin-proteasome dysfunction in α-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death. J. Pharmacol. Exp. Ther. 315, 69–79.10.1124/jpet.105.084632Search in Google Scholar PubMed

Sunderland, T., Linker, G., and Mirza, N. (2003). Decreased-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. J. Am. Med. Assoc. 289, 2094–2103.10.1001/jama.289.16.2094Search in Google Scholar PubMed

Szargel, R., Rott, R., and Engelender, S. (2008). Synphilin-1 isoforms in Parkinson’s disease: regulation by phosphorylation and ubiquitylation. Cell. Mol. Life Sci. 65, 80–88.10.1007/s00018-007-7343-0Search in Google Scholar PubMed

Tang, Y.P. and Gershon, E.S. (2003). Genetic studies in Alzheimer’s disease. Dialogues Clin. Neurosci. 5, 17–26.10.31887/DCNS.2003.5.1/yptangSearch in Google Scholar

Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.O., Westman, E., Kinsey, A., and Güntert, A. (2010). Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch. Gen. Psychiatry 67, 739–748.10.1001/archgenpsychiatry.2010.78Search in Google Scholar PubMed PubMed Central

Uversky, V.N., Li, J., and Fink, A.L. (2001). Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson’s disease. FEBS Lett. 500, 105–108.10.1016/S0014-5793(01)02597-2Search in Google Scholar

Valente, E.M., Abou-Sleiman, P.M., and Caputo, V. (2004). Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304, 1158–1160.10.1126/science.1096284Search in Google Scholar PubMed

Varghese, T., Sheelakumari, R., James, J.S., and Mathuranath, P.S. (2013). A review of neuroimaging biomarkers of Alzheimer’s disease. Neurol. Asia 18, 239–248.Search in Google Scholar

Vattikuti, S. and Chow, C.C. (2010). A computational model for cerebral cortical dysfunction in autism spectrum disorders. Biol. Psychiatry 67, 672–678.10.1016/j.biopsych.2009.09.008Search in Google Scholar PubMed PubMed Central

Velayudhan, L., Killick, R., Hye, A., Kinsey, A., Guntert, A., Lynham, S., Ward, M., Leung, R, Lourdusamy, A. and To, A.W.M. (2012). Plasma transthyretin as a candidate marker for Alzheimer’s disease. J. Alzheimers Dis. 28, 369–375.10.3233/JAD-2011-110611Search in Google Scholar PubMed

Walton, J.R. and Wang, M.X. (2009). APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer’s disease. J. Inorg. Biochem. 103, 1548–1554.10.1016/j.jinorgbio.2009.07.027Search in Google Scholar PubMed

Wang, J., Hoekstra, J.G., Zuo, C., Cook, T.J., and Zhang, J. (2012). Biomarkers of Parkinson’s disease: current status and future. Drug Discov. Today 18, 155–162.10.1016/j.drudis.2012.09.001Search in Google Scholar PubMed PubMed Central

Wang, Y., Wang, X., Li, R., Yang, Z.F., Wang, Y.Z., Gong, X.L., and Wang, X.M. (2013). A DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson’s disease-related genes in dopaminergic neurons. CNS Neurosci. Ther. 19, 183–190.10.1111/cns.12059Search in Google Scholar PubMed PubMed Central

Wang, H.A., Lin, Z.L., Yu, X.F., Bao, Y., Cui, X., and Kim, N. (2016). Computational prediction of Alzheimer’s and Parkinson’s disease microRNAs in domestic animals. Asian-Australas. J. Anim. Sci. 29, 782–792.10.5713/ajas.15.0413Search in Google Scholar PubMed PubMed Central

Ward, J.B., Jr. and Henderson, R.E. (1996). Identification of needs in biomarker research. Environ. Health Perspect. 104(Supplement 5), 895–900.10.1289/ehp.96104s5895Search in Google Scholar PubMed PubMed Central

Westerhoff, H.V. (2011). Systems biology left and right. Methods Enzymol. 500, 3–11.10.1016/B978-0-12-385118-5.00001-3Search in Google Scholar PubMed

WHO. (2003). Investing in Mental Health. Department of Mental Health and Substance Dependence, Noncommunicable Diseases and Mental Health. Geneva: World Health Organization. www.who.int.Search in Google Scholar

Wider, C., Foroud, T., and Wszolek, Z.K. (2010). Clinical implications of gene discovery in Parkinson’s disease and Parkinsonism. Mov. Disord. 25, S15–S20.10.1002/mds.22723Search in Google Scholar

Wills, J., Credle, J., Oaks, A.W., Duka, V., Lee, J.H., and Jones, J. (2012). Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways. PLoS One 7, e30745.10.1371/journal.pone.0030745Search in Google Scholar

Wu, J. and Xie, H. (2014). Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons. Artif. Cells Nanomed. Biotechnol. 44, 690–694.10.3109/21691401.2014.980507Search in Google Scholar

Wu, J., Basha, M.R., Brock, B., Cox, D P., Cardozo-Pelaez, F., and Mcpherson, C.A. (2008). Alzheimer’s disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 28, 3–9.10.1523/JNEUROSCI.4405-07.2008Search in Google Scholar

Wu. J., Wang. C., Sun. J., and Xue. Y. (2011). Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 5, 4476–4489.10.1021/nn103530bSearch in Google Scholar

Yamaguchi, M., Kokai, Y., Imai, S., Utsumi, K., Matsumoto, K., Honda, H., Mizue, Y., Momma, M., Maeda, T., and Toyomasu, S. (2010). Investigation of annexin A5 as a biomarker for Alzheimer’s disease using neuronal cell culture and mouse model. J. Neurosci. Res. 88, 2682–2692.10.1002/jnr.22427Search in Google Scholar

Yamamoto, H., Saitoh, Y., Yasugawa, S., and Miyamoto, E. (1990). Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions and inhibition by aluminum. J. Neurochem. 55, 683–690.10.1111/j.1471-4159.1990.tb04187.xSearch in Google Scholar

Yamin, G., Glaser, C.B., Uversky, V.N., and Fink, A.L. (2003). Certain metals trigger fibrillation of methionine-oxidized α-synuclein. J. Biol. Chem. 278, 27630–27635.10.1074/jbc.M303302200Search in Google Scholar

Yang, X., He, C., Li, J., Chen, H., Ma, Q., and Sui, X. (2014). Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells. Toxicol. Lett. 229, 240–249.10.1016/j.toxlet.2014.05.009Search in Google Scholar

Young, R.A. (2000). Biomedical discovery with DNA arrays. Cell 102, 9–15.10.1016/S0092-8674(00)00005-2Search in Google Scholar

Zarazúa, S., Bürger, S., Delgado, J.M., Jiménez-Capdeville, M.E., and Schliebs, R. (2011). Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of human APP. Int. J. Dev. Neurosci. 29, 389–396.10.1016/j.ijdevneu.2011.03.004Search in Google Scholar PubMed

Zhang, Z.H., Huang, H., Wu, C.H., Jung, M., Dritschilo, A., Riegel, A.T., and Wellstein, A. (2011). Omics-based molecular target and biomarker identification. Methods Mol. Biol. 719, 547–571.10.1007/978-1-61779-027-0_26Search in Google Scholar PubMed PubMed Central

Zhao, Y., Tan, W., Sheng, W., and Li, X. (2016). Identification of biomarkers associated with Alzheimer’s disease by bioinformatics analysis. Am. J. Alzheimers Dis. Other Demen. 31, 163–168.10.1177/1533317515588181Search in Google Scholar PubMed

Zhu, Q., Lajiness, M.S., and Ding, Y. (2010). WENDI: a tool for finding non-obvious relationships between compounds and biological properties, genes, diseases and scholarly publications. J. Cheminform. 2, 1–9.10.1186/1758-2946-2-6Search in Google Scholar PubMed PubMed Central